Acadia Pharmaceuticals
(NASDAQ) ACAD
Acadia Pharmaceuticals Financials at a Glance
Market Cap
$3.71B
Revenue (TTM)
$1.07B
Net Income (TTM)
$391.00M
EPS (TTM)
$2.29
P/E Ratio
9.50
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$21.73
Volume
25,894
Open
$22.57
Price
$21.73
Volume
25,894
Open
$22.57
Previous Close
$21.73
Daily Range
$21.42 - $22.57
52-Week Range
$14.08 - $28.35
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$21.73
Volume
25,894
Open
$22.57
Previous Close
$21.73
Daily Range
$21.42 - $22.57
52-Week Range
$14.08 - $28.35
ACAD News
ACAD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Acadia Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
798
CEO
Catherine Owen Adams
Website
www.acadia.comHeadquarters
San Diego, CA 92130, US
ACAD Financials
Key Financial Metrics (TTM)
Gross Margin
92%
Operating Margin
10%
Net Income Margin
36%
Return on Equity
40%
Return on Capital
8%
Return on Assets
25%
Earnings Yield
10.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.71B
Shares Outstanding
170.50M
Volume
25.89K
Short Interest
0.00%
Avg. Volume
1.67M
Financials (TTM)
Gross Profit
$982.51M
Operating Income
$104.81M
EBITDA
$138.90M
Operating Cash Flow
$109.84M
Capital Expenditure
$4.69M
Free Cash Flow
$105.15M
Cash & ST Invst.
$819.69M
Total Debt
$52.19M
Acadia Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$283.99M
+9.4%
Gross Profit
$257.76M
+8.4%
Gross Margin
90.77%
N/A
Market Cap
$3.71B
N/A
Market Cap/Employee
$5.68M
N/A
Employees
653
N/A
Net Income
$273.57M
+90.3%
EBITDA
$26.32M
+115.7%
Quarterly Fundamentals
Net Cash
$767.50M
+9.0%
Accounts Receivable
$148.23M
+41.6%
Inventory
$34.67M
+58.0%
Long Term Debt
$40.55M
-3.5%
Short Term Debt
$11.63M
+16.8%
Return on Assets
25.00%
N/A
Return on Invested Capital
8.14%
N/A
Free Cash Flow
$52.74M
-232.1%
Operating Cash Flow
$48.73M
-220.7%